NRX Pharmaceuticals (NRXP) Shares Outstanding (Diluted) (2020 - 2026)
NRX Pharmaceuticals (NRXP) Shares Outstanding (Diluted) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,102.16 Bn | 67,101.87 Bn | - | 52.24 Mn |
| 2 | Nanobiotix | 1,913.50 Bn | 1,913.44 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | 118.76 Bn |
| 4 | BeOne Medicines | 473.74 Bn | 468.95 Bn | 1.35 Bn | 1.51 Bn |
| 5 | Vertex Pharmaceuticals | 122.07 Bn | 114.82 Bn | 2.59 Bn | 256.30 Mn |
| 6 | Regeneron Pharmaceuticals | 70.00 Bn | 61.24 Bn | 3.31 Bn | 107.70 Mn |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - | 680.00 |
| 8 | Argenx Se | 55.96 Bn | 50.77 Bn | 1.41 Bn | 64.41 Mn |
| 9 | Alnylam Pharmaceuticals | 37.49 Bn | 34.48 Bn | 959.66 Mn | 138.23 Mn |
| 10 | NRX Pharmaceuticals | 117.34 Mn | 110.64 Mn | 437,000.00 | 8.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.85 Mn |
| Dec 31, 2025 | 8.85 Mn |
| Sep 30, 2025 | 8.85 Mn |
| Jun 30, 2025 | 8.85 Mn |
| Mar 31, 2025 | 8.85 Mn |
| Dec 31, 2024 | 8.85 Mn |
| Sep 30, 2024 | 8.85 Mn |
| Jun 30, 2024 | 8.85 Mn |
| Mar 31, 2024 | 8.85 Mn |
| Dec 31, 2023 | 8.19 Mn |
| Sep 30, 2023 | 8.19 Mn |
| Jun 30, 2023 | 7.32 Mn |
| Mar 31, 2023 | 6.75 Mn |
| Dec 31, 2022 | 6.58 Mn |
| Sep 30, 2022 | 6.64 Mn |
| Jun 30, 2022 | 6.57 Mn |
| Mar 31, 2022 | 6.37 Mn |
| Dec 31, 2021 | 4.69 Mn |
| Sep 30, 2021 | 5.11 Mn |
| Jun 30, 2021 | 4.17 Mn |